← All trials
NCT00158574
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2005
- Primary completion
- Apr 1, 2008
- Completion date
- Jun 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 2419
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- University of LondonLead sponsor
- University of LondonOverall official - principal investigator
- University of LondonStudy director
- University of CopenhagenCollaborator
- National Institute for Medical Research, TanzaniaCollaborator
- Kilimanjaro Christian Medical College, TanzaniaCollaborator
- University of LondonReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.